Publications by authors named "Rob Verhoeven"

Claim this Profile
N
National indication protocol for proton radiotherapy in esophageal cancer patients in the Netherlands.
Christina T Muijs, Yvonne L B Klaver, Joost Nuyttens, Irene M Lips, Karin Muller, Rob Verhoeven

Radiother Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of waiting time from diagnosis to neoadjuvant chemoradiotherapy on interval distant metastases in esophageal cancer patients: A study based on the Netherlands cancer registry.
Jingpu Wang, Zhouqiao Wu, Lucas Goense, Rob H A Verhoeven, Jelle P Ruurda

Eur J Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel TRG-N Prognostic Classification System for Esophageal Cancer Undergoing Neoadjuvant Therapy Followed by Esophagectomy: A Study Based on the Netherlands Cancer Registry.
Jingpu Wang, Zhouqiao Wu, Rob H A Verhoeven, Lucas Goense, Nadia Haj Mohammad

Ann Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: A population-based comparison.
Benthe H Doeve, Steven C Kuijper, Geert Silversmit, Lien van Walle, Philippe Nafteux, Rob H A Verhoeven

Int J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital variation in treatment for synchronous metastatic esophageal and gastric cancer: A nationwide population-based study in the Netherlands.
Julie F M Geerts, Pauline A J Vissers, Bianca Mostert, Bas P L Wijnhoven, Brigitte C M Haberkorn, Rob H A Verhoeven

Int J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab Deruxtecan Versus Ramucirumab-Paclitaxel as Second-Line Therapy for Patients With HER2-Positive Gastric or GEJ Adenocarcinoma.
Rob H A Verhoeven, Steven C Kuijper, Florian Lordick, Marije Slingerland, Amy Qin

J Natl Compr Canc Netw· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real-world matched comparison of overall survival.
Rob H A Verhoeven, Steven C Kuijper, Marije Slingerland, Bas Wijnhoven, Mark I van Berge Henegouwen

Int J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost-effectiveness analysis of the effect of hospital variation in the probability of providing treatment with curative intent in potentially curable esophageal and gastric cancer patients.
Saskia P M Truijen, Pauline A J Vissers, Grard A P Nieuwenhuijzen, Maurice J C van der Sangen, Peter D Siersema, Rob H A Verhoeven

Dis Esophagus· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incomplete neoadjuvant chemo(radio)therapy negatively impacts pathological response and overall survival in locally advanced esophageal cancer.
Denice Kamp, Samuel Noya, Stella Mook, Jelle P Ruurda, Richard van Hillegersberg, Rob H A Verhoeven

Eur J Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival scenarios of patients with localized and metastatic pancreatic adenocarcinoma: A population-based study.
Steven C Kuijper, Anne M Gehrels, Lydia G van der Geest, Rob H A Verhoeven, Bas Groot Koerkamp

Int J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations to forgo systemic treatment in patients with advanced esophageal or gastric cancer: A real-world evidence study.
Ellis Slotman, Marieke Pape, Hanneke W M van Laarhoven, Roos E Pouw, Yvette M van der Linden, Rob H A Verhoeven

Int J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automating Performance Status Annotation in Oncology Using Llama-3.
Irene Cara, Nynke van 't Hof, Sebastiaan Siegerink, Linde Veen, Gijs Geleijnse, Rob Verhoeven

Stud Health Technol Inform· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of peritoneal metastases in patients with gastric cancer: a nationwide population-based study.
Niels A D Guchelaar, Micha J de Neijs, Bo J Noordman, Heilida E C Graaf, Irene E G van Hellemond, Rob H A Verhoeven

EClinicalMedicine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histopathological response to chemotherapy and survival of mucinous type gastric cancer.
Irene A Caspers, Astrid E Slagter, Pauline A J Vissers, Martha Lopez-Yurda, Laurens V Beerepoot, Rob H A Verhoeven

J Natl Cancer Inst· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: a nationwide cohort study in the Netherlands.
Hanneke van Laarhoven, Rob Verhoeven, Mark van Berge Henegouwen, Nadia Haj Mohammad, Richard van Hillegersberg

EClinicalMedicine· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastric Cancer Risk among Immigrants and Socioeconomic Groups in the Netherlands.
Duco T Mülder, Hilliene J van de Schootbrugge-Vandermeer, James F O'Mahony, Dianqin Sun, Weiran Han, Rob H A Verhoeven

Cancer Epidemiol Biomarkers Prev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient access to perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin and docetaxel in patients with resectable gastric cancer in the Netherlands.
Julie F M Geerts, Marieke Pape, Pauline A J Vissers, Rob H A Verhoeven, Bianca Mostert

Eur J Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Treatment Strategies and Survival of Patients with cT4bM0 Esophageal Cancer: A Nationwide Cohort Study.
Jingpu Wang, Eline M de Groot, Zhouqiao Wu, Rob H A Verhoeven, Nadia Haj Mohammad

Dig Surg· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Treatment Strategies and Outcomes of Patients With Synchronous Peritoneal Metastases of Gastric Origin: A Nationwide Population-Based Study.
Niels A D Guchelaar, Bo J Noordman, Marion W Welten, Myron T van Santen, Micha J de Neijs, Rob H A Verhoeven

J Natl Compr Canc Netw· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
Anouk Rijken, Marieke Pape, Geert A Simkens, Ignace H J T de Hingh, Misha D P Luyer, Rob H A Verhoeven

Int J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study.
Emma C Gertsen, Arjen van der Veen, Hylke J F Brenkman, Lodewijk A A Brosens, Rachel S van der Post, Rob H A Verhoeven

Ann Surg Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-positive peritoneal cytology in patients with gastric cancer is associated with poor outcome: A nationwide study.
Karen Van Der Sluis, Steven N Taylor, Liudmila L Kodach, Jolanda M van Dieren, Ignace H J T de Hingh, Rob H A Verhoeven

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Chemotherapy for Gastro-Esophageal or Gastric Cancer: Anthracyclin Triplets versus FLOT.
Julie F M Geerts, Charlène J van der Zijden, Pieter C van der Sluis, Manon C W Spaander, Grard A P Nieuwenhuijzen, Rob H A Verhoeven

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing real-world representativeness of prospective registry cohorts in oncology: insights from patients with esophagogastric cancer.
Steven C Kuijper, Joost Besseling, Thomas Klausch, Marije Slingerland, Charlène J van der Zijden, Rob H A Verhoeven

J Clin Epidemiol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between hospital variation in curative treatment for esophagogastric cancer and health-related quality of life and survival.
Pauline A J Vissers, Josianne C H B M Luijten, Valery E P P Lemmens, Hanneke W M van Laarhoven, Marije Slingerland, Rob H A Verhoeven

Eur J Surg Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis